Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-rhamnosyl-glucosyl Quercetin
2. Quercetin 3 Rutinoside
3. Quercetin, 3-rhamnosyl-glucosyl
4. Quercetin-3-rutinoside
5. Rutoside
1. 153-18-4
2. Rutoside
3. Quercetin 3-rutinoside
4. Birutan
5. Phytomelin
6. Myrticolorin
7. Eldrin
8. Globulariacitrin
9. Rutin Trihydrate
10. Ilixanthin
11. Osyritrin
12. Paliuroside
13. Tanrutin
14. Sophorin
15. Bioflavonoid
16. Globularicitrin
17. Rutabion
18. Venoruton
19. 3-rutinosyl Quercetin
20. Violaquercitrin
21. Yunxianggan
22. 3-rhamnoglucosylquercetin
23. Rutine
24. Rutozyd
25. Melin
26. Quercetin 3-o-rutinoside
27. Rutinic Acid
28. Birutan Forte
29. Quercetin-3-rutinoside
30. Oxyritin
31. Rutinum
32. Rutosido
33. Rutosidum
34. Rutinion Acid
35. Vitamin P
36. Quercitin 3-rutinoside
37. Novarrutina
38. Violaquercetrin
39. Birutin
40. Quercetin Rhamnoglucosine
41. Quercetin-3-o-rutinoside
42. Quercetin-3beta-rutinoside
43. Quercetin 3-rhamnoglucoside
44. Quercetol 3-rhamnoglucoside
45. C.i. 75730
46. Rutosid
47. Rutoside [inn]
48. 3,3',4',5,7-pentahydroxyflavone-3-rutinoside
49. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
50. Quercetin 3-o-beta-d-rutinoside
51. 5g06tvy3r7
52. Chembl226335
53. Chebi:28527
54. Rutoside (inn)
55. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
56. 3-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
57. 3-rhamnoglucoside Of 3,3',4',5,7-pentahydroxyflavone
58. Ncgc00160628-01
59. Nsc-9220
60. Dsstox_cid_2326
61. Dsstox_rid_76549
62. Dsstox_gsid_22326
63. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
64. 4h-1-benzopyran-4-one,3-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
65. Rut
66. Rutoside (rutin)
67. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
68. 3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
69. Cas-153-18-4
70. Smr000112560
71. Rutin [jan:nf]
72. Rutosidum [inn-latin]
73. Rutosido [inn-spanish]
74. Usaf Cf-5
75. Unii-5g06tvy3r7
76. Neoisorutin
77. Ccris 7564
78. Rutinoside, Quercetin-3, Beta-
79. Hydroxyethylrutoside
80. Rutin (rutoside)
81. Venoruton (tn)
82. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-mannopyranoside
83. Nsc 9220
84. Einecs 205-814-1
85. Mfcd00006830
86. Rutin,(s)
87. Brn 0075455
88. 3,3',4',5,7-pentahydroxyflavone 3-rutinoside
89. Ai3-19098
90. Rutin [vandf]
91. Rutin [inci]
92. 207671-50-9
93. Rutin [dsc]
94. Rutin [usp-rs]
95. Rutin [mi]
96. Rutoside [inn:jan:nf]
97. Rutoside [who-dd]
98. Beta-quercetin-3-rutinoside
99. Bidd:pxr0020
100. Schembl23243
101. 4h-1-benzopyran-4-one, 3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
102. 5-18-05-00519 (beilstein Handbook Reference)
103. Mls000759398
104. Mls001424098
105. Bidd:er0377
106. Divk1c_000644
107. Megxp0_000068
108. Rutin From Sophora Japonica L.
109. Dtxsid3022326
110. Acon1_000075
111. Cid_5280805
112. Hms502a06
113. Kbio1_000644
114. Rutin (95%)
115. Ninds_000644
116. 3,3',4',5,7-pentahydroxyflavone-3-rhamnoglucoside
117. Hms2051b06
118. 3'4'5,7-tetoh-flavone-3-rut
119. Flavone, 3,3',4',5,7-pentahydroxy-, 3-(o-rhamnosylglucoside)
120. Hy-n0148
121. Zinc4096846
122. Quercetin 3-o-beta-delta-rutinoside
123. Tox21_111945
124. Tox21_202602
125. Bdbm50217942
126. Glucopyranoside, Quercetin-3 6-o-alpha-l-rhamnopyranosyl-, Beta-d
127. Quercetin, 3-(6-o-alpha-l-rhamnopyranosyl-beta-d-glucopyranoside)
128. S2350
129. 3,3',4',5,5',7-hexahydroxyflavone (6-o-alpha-l-rhamnosyl-beta-d-glucoside)
130. Akos015895432
131. Glucopyranoside, Quercetin-3 6-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
132. Quercetin, 3-(6-0-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
133. Tox21_111945_1
134. Ccg-100999
135. Cs-5573
136. Db01698
137. Ds-9708
138. Nc00249
139. Idi1_000644
140. Rutinoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-3-yl
141. Ncgc00160628-02
142. Ncgc00160628-03
143. Ncgc00260150-01
144. 4h-1-benzopyran-4-one, 3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
145. Methyltetrahydro-2h-pyran-2-yloxy)methyl)
146. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3
147. R0035
148. C05625
149. D08499
150. Ab00374708-09
151. Tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
152. A809400
153. Q407857
154. Sr-01000759399
155. Q-201691
156. Sr-01000759399-5
157. A8241da0-6ec6-48ba-bd10-3f7bd61d42ce
158. Brd-k20482099-001-01-1
159. Brd-k20482099-001-11-0
160. 3,3,4,5,7-pentahydroxyflavone-3-rhamnoglucoside
161. 3-rhamnoglucoside Of 5,7,3',4'-tetrahydroxyflavonol
162. Quercetin 3-o-[alpha-l-rhamnosyl-(1->6)-beta-d-glucoside]
163. Quercetin 3-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucopyranoside
164. Rutin (quercetin-3-o-rutinoside) (constituent Of Ginkgo) [dsc]
165. Rutin (quercetin-3-o-rutinoside) (constituent Of Hawthorn Leaf With Flower) [dsc]
166. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one;rutin
167. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
168. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4h-chromen-4-one
169. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-chromen-4-one-3-yl 6-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucoside
170. 4h-1-benzopyran-4-one, 3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]-oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
Molecular Weight | 610.5 g/mol |
---|---|
Molecular Formula | C27H30O16 |
XLogP3 | -1.3 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 6 |
Exact Mass | 610.15338487 g/mol |
Monoisotopic Mass | 610.15338487 g/mol |
Topological Polar Surface Area | 266 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 1020 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
C05CA01
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
C - Cardiovascular system
C05 - Vasoprotectives
C05C - Capillary stabilizing agents
C05CA - Bioflavonoids
C05CA01 - Rutoside
Date of Issue : 2022-08-11
Valid Till : 2025-06-26
Written Confirmation Number : WC-0054
Address of the Firm :
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26727
Submission : 2012-11-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26287
Submission : 2012-06-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32
Submission : 1946-12-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26509
Submission : 2012-09-28
Status : Inactive
Type : II
Certificate Number : R0-CEP 2005-241 - Rev 00
Issue Date : 2008-09-29
Type : Chemical
Substance Number : 1795
Status : Withdrawn by Holder
Certificate Number : CEP 2011-383 - Rev 01
Issue Date : 2024-05-23
Type : Chemical
Substance Number : 1795
Status : Valid
Certificate Number : R1-CEP 2004-155 - Rev 01
Issue Date : 2010-11-08
Type : Chemical
Substance Number : 1795
Status : Valid
Certificate Number : CEP 2017-267 - Rev 02
Issue Date : 2024-11-15
Type : Chemical
Substance Number : 1795
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26287
Submission : 2012-06-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26727
Submission : 2012-11-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26509
Submission : 2012-09-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32
Submission : 1946-12-12
Status : Inactive
Type : II
Certificate Number : CEP 2006-129 - Rev 03
Status : Valid
Issue Date : 2024-08-21
Type : Chemical
Substance Number : 1795
Certificate Number : CEP 2011-383 - Rev 01
Status : Valid
Issue Date : 2024-05-23
Type : Chemical
Substance Number : 1795
Certificate Number : CEP 2017-267 - Rev 02
Status : Valid
Issue Date : 2024-11-15
Type : Chemical
Substance Number : 1795
Certificate Number : R0-CEP 2013-253 - Rev 00
Status : Expired
Issue Date : 2014-10-15
Type : Chemical
Substance Number : 1795
Certificate Number : R1-CEP 2004-155 - Rev 01
Status : Valid
Issue Date : 2010-11-08
Type : Chemical
Substance Number : 1795
Certificate Number : R0-CEP 2005-241 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2008-09-29
Type : Chemical
Substance Number : 1795
Certificate Number : R0-CEP 2014-236 - Rev 01
Status : Expired
Issue Date : 2017-04-25
Type : Chemical
Substance Number : 1795
Date of Issue : 2022-08-11
Valid Till : 2025-06-26
Written Confirmation Number : WC-0054
Address of the Firm : Block No. 82/B, ECP Road, At & Post. Karakhadi, Tal-Padra, City Karakhadi -39145...
About the Company : As an ISO9001, ISO22000 certificated supplier, Basic Nutrition supply high-quality ingredients for nutraceuticals. We can offer a range of products from small to large quantites: h...
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
About the Company : Specializing in natural & oncology APIs, we establish R&D and production platforms for new salt, crystal form & synthetic biology research. We cooperate with clients for IND, NDA, ...
About the Company : Allastir instituted the services in 2010 with a motive to cater the pharmaceutical industry with niche API's. In Allastir we strongly believe in team work and customer satisfaction...
About the Company : Alpspure Lifesciences Pvt. Ltd. epitomizes purity and quality as a prominent Indian conglomerate renowned for delivering a diverse range of authentic active ingredients. Built on a...
About the Company : Bio-gen Extracts Pvt. Ltd., India, established in the year 2000, is a GMP Certified fine chemicals company that specializes in the process development and manufacture of Active Pha...
About the Company : Bio-gen Extracts Pvt. Ltd., India, established in the year 2000, is a GMP Certified fine chemicals company that specializes in the process development and manufacture of Active Pha...
About the Company : Bio-gen Extracts Pvt. Ltd., India, established in the year 2000, is a GMP Certified fine chemicals company that specializes in the process development and manufacture of Active Pha...
About the Company : Chengdu Chen Green Biotechnology (Chen Green) is a company specializing in plant extracts, pharmaceutical raw materials, food additives and dietary supplements manufacturers and wh...
About the Company : Chengdu Yazhong Bio-pharmaceutical Co., Ltd., founded in 2002, is a leading company with plant extracts, APIs and medical intermediates. Our company is equipped with GMP approved m...
About the Company : Hunan Bitian Technology Co.,Ltd is dedicate to R&D, Manufacturing and Distribution of Natural Ingredients, Natural Colors, Natrual Fruit & Vegetable Powder, Cosmetic Materials and ...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Novos vital is a groundbreaking supplement chew scientifically formulated with an ingredient blend shown to support and optimize essential organ functions that decline with age.
Lead Product(s): Trehalose API,Nattokinase,Rutin
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Novos Vital
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 21, 2024
Lead Product(s) : Trehalose API,Nattokinase,Rutin
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
NOVOS Launches Daily Chew to Optimize and Maintain Essential Organ Function
Details : Novos vital is a groundbreaking supplement chew scientifically formulated with an ingredient blend shown to support and optimize essential organ functions that decline with age.
Brand Name : Novos Vital
Molecule Type : Small molecule
Upfront Cash : Not Applicable
February 21, 2024
Details:
Through the acquisition, Sun Pharma strengthen its anti-inflammatory portfolio by adding Disperzyme (bromelain), Disperzyme-CD and Phlogam from Aksigen Hospital Care.
Lead Product(s): Bromelain,Trypsin,Rutin
Therapeutic Area: Neurology Brand Name: Disperzyme
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Sun Pharmaceutical Industries Limited
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition January 30, 2023
Sun Pharma Acquires Disperzyme® and Phlogam® Brands to Strengthen Its Anti-Inflammatory Portfoli...
Details : Through the acquisition, Sun Pharma strengthen its anti-inflammatory portfolio by adding Disperzyme (bromelain), Disperzyme-CD and Phlogam from Aksigen Hospital Care.
Brand Name : Disperzyme
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 30, 2023
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Gericomplex
Dosage Form : CAP
Dosage Strength : 20mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Gericomplex
Dosage Form : CAP
Dosage Strength : 20mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Vietnam
Brand Name : Franvit C Rutin
Dosage Form : Tablet
Dosage Strength : 100MG; 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Paroven
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 50X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Vietnam
Nattokinase; Ginkgo Biloba; Magnesium Oxide; Rutin; Citicoline Sodium; Coenzyme Q-10; Omega 3 fatty acid; Vitamin B6
Brand Name : Brain Forte
Dosage Form :
Dosage Strength : 750IU; 40MG; 20MG; 10MG; 5MG; 5MG; 1500MCG; 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
Regulatory Info : Generic
Registration Country : China
Brand Name :
Dosage Form : TABLET
Dosage Strength : 20MG; 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : China
Regulatory Info : Generic
Registration Country : China
Brand Name :
Dosage Form : TABLET
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : China
Related Excipient Companies
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Excipients by Applications
Dosage Form : Tablet
Grade : Not Available
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Market Place
Reply
07 Aug 2024
Reply
25 Jul 2024
Reply
23 Aug 2023
Reply
12 Oct 2022
Reply
28 Apr 2022
Reply
29 Mar 2022
Reply
29 Dec 2021
Reply
05 Dec 2020
Reply
18 Jun 2020
Reply
17 Apr 2020
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?